This review explores management strategies such as fresh frozen plasma, icatibant, ecallantide, and C1 inhibitor concentrate, and considers alternative drug options like angiotensin II receptor blockers and potential associations of DPP-4 inhibitors with ACE inhibitor-induced angioedema. Here, ACE is linked to angioedema.